https://www.google.com/amp/s/www.cnbc.com/amp/2025/01/13/eli-lilly-new-weight-loss-pill.html
Eli Lilly expects its experimental weight loss pill, Orforglipron, to be approved as soon as early next year. Data on the tablet are expected to be ready within the next six months, which could lead to approval as early as 2026.
The pill is part of a class of drugs known as incretins designed to mimic the action of the GLP-1 hormone. Drugs from the class are also being tested to treat or prevent Alzheimer's by helping with underlying conditions like obesity and stroke that lead to cognitive decline.
Eli Lilly has said Orforglipron helped patients lose up to 14.7% of their weight in a mid-stage trial, compared with 2.3% among people who took a placebo.
https://medwatch.com/News/Pharma___Biotech/article17804939.ece
https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-exec-expects-obesity-pill-data-april-2025-2024-06-10/
Good news!